Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-04

Clinical Trial Update: Treatment of Refractory Status Epilepticus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for treatment of refractory status epilepticus was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Status Epilepticus | Phase 3 | Status: TERMINATED | Results posted: 2013-04-04